Write in a clean editor, then format for Annals of Clinical and Translational Neurology in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Annals of Clinical and Translational Neurology is a peer-reviewed journal published by Wiley, covering Multiple Sclerosis Research Studies, Amyotrophic Lateral Sclerosis Research, Genetic Neurodegenerative Diseases.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Annals of Clinical and Translational Neurology 12 (3): 45–58.
Formats any DOI in Annals of Clinical and Translational Neurology style. No sign-up. |
| Publishes research in | Multiple Sclerosis Research Studies Amyotrophic Lateral Sclerosis Research Genetic Neurodegenerative Diseases Epilepsy research and treatment Parkinson's Disease Mechanisms and Treatments |
| ISSN | 2328-9503 |
| Citation impact (2-yr) | 3.44 |
| h-index | 98 |
| i10-index | 1,527 |
| Total citations | 65,747 |
| Article processing charge | $3,300 |
| Open access | Yes |
| Top institutions publishing here | Harvard University |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Abstract Objective Most SARS‐CoV‐2‐infected individuals never require hospitalization. However, some develop prolonged symptoms. We sought to characterize the spectrum of neurologic manifestations in non‐hospitalized Covid‐19 “long haulers”. Methods This is a prospective study of the first 100 consecutive patients (50 SARS‐CoV‐2 laboratory‐positive (SARS‐CoV‐2 + ) and 50 laboratory‐negative (SARS‐CoV‐2 ‐ ) individuals) presenting to our…
Abstract Objective The Parkinson's Progression Markers Initiative ( PPMI ) is an observational, international study designed to establish biomarker‐defined cohorts and identify clinical, imaging, genetic, and biospecimen Parkinson's disease ( PD ) progression markers to accelerate disease‐modifying therapeutic trials. Methods A total of 423 untreated PD , 196 Healthy Control ( HC ) and 64…
We have developed a novel real-time quaking-induced conversion RT-QuIC-based assay to detect alpha-synuclein aggregation in brain and cerebrospinal fluid from dementia with Lewy bodies and Parkinson's disease patients. This assay can detect alpha-synuclein aggregation in Dementia with Lewy bodies and Parkinson's disease cerebrospinal fluid with sensitivities of 92% and 95%, respectively, and with an overall…
OBJECTIVE: Covid-19 can involve multiple organs including the nervous system. We sought to characterize the neurologic manifestations, their risk factors, and associated outcomes in hospitalized patients with Covid-19. METHODS: We examined neurologic manifestations in 509 consecutive patients admitted with confirmed Covid-19 within a hospital network in Chicago, Illinois. We compared the severity of Covid-19 and…
Brain-computer interfaces (BCIs) can provide sensory feedback of ongoing brain oscillations, enabling stroke survivors to modulate their sensorimotor rhythms purposefully. A number of recent clinical studies indicate that repeated use of such BCIs might trigger neurological recovery and hence improvement in motor function. Here, we provide a first meta-analysis evaluating the clinical effectiveness of BCI-based…
